TCL Archive Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage February 28, 2014
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
